OPGEN INC OPGN Income Statement

Opgen inc (OPGN)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Revenue
Total revenue
3,095	3,498	3,436	3,340	3,120	2,946	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	3,311	3,524	3,974	4,173	3,464	2,701	1,827	1,166	1,120	1,236	0	0	0
Laboratory services
-	-	-	-	-	-	-	-	-	-	-	-	115	228	215	216	214	120	186	251	344	478	0	0	0
Collaboration revenue
-	-	-	-	-	-	-	-	-	-	-	-	293	272	159	180	83	336	936	1,386	2,036	2,411	0	0	0
Total revenue
-	-	-	-	-	-	-	-	-	-	-	-	3,720	4,025	4,348	4,569	3,762	3,157	2,950	2,804	3,501	4,126	0	0	0
Operating expenses
Cost of products sold (excluding depreciation and amortization)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Cost of services (excluding depreciation and amortization)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Total costs of sales (excluding depreciation and amortization)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Gross profit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Cost of products sold
-	-	-	-	-	-	-	-	-	-	-	-	1,737	1,658	1,474	1,699	1,410	1,179	0	0	0	-	-	0	0
Cost of services
-	-	-	-	-	-	-	-	-	-	-	-	415	631	697	694	588	367	0	0	0	-	-	0	0
Research and development
4,562	5,121	5,925	6,072	6,223	5,677	5,306	5,533	5,991	6,883	7,545	8,210	8,782	8,613	8,571	8,181	6,847	6,002	5,035	4,276	4,524	4,368	0	0	0
General and administrative
6,206	6,252	6,605	6,788	7,026	7,069	6,738	6,595	6,513	6,692	6,967	7,006	7,033	6,602	7,095	7,070	6,713	5,834	4,373	3,314	2,417	2,312	0	0	0
Sales and marketing
1,374	1,464	1,556	1,541	1,574	1,531	1,539	1,508	1,991	2,767	3,591	4,556	5,235	5,529	5,625	5,363	4,680	4,305	3,467	2,893	2,534	2,058	0	0	0
Transaction costs
0	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of right-of-use asset
-	520	520	520	520	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of intangibles assets
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Transaction expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-
Total operating expenses
15,599	15,769	16,883	16,592	17,046	16,126	15,608	15,768	16,616	18,476	20,277	21,900	23,204	23,035	22,950	0	0	-	0	-	-	-	-	-	-
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,311	10,404	9,691	0	0	0
Operating loss
-12,503	-12,271	-13,446	-13,251	-13,926	-13,180	-12,430	-12,396	-13,330	-15,265	-17,050	-18,659	-19,484	-19,009	-19,117	-18,965	-17,004	-15,059	-11,579	-8,506	-6,903	-5,564	0	0	0
Other income (expense)
Other income (expense)
-	-	0	0	-	-	0	0	0	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Interest and other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Interest and other income (expense)
0	-	-	-	0	-	-	-	-	-	-	0	0	-	-	5	0	-	0	0	-	-	-	-	-
Interest expense
169	187	193	172	189	191	199	262	261	233	207	158	131	143	164	140	1,746	1,801	1,810	1,825	199	111	0	0	0
Foreign currency transaction losses
8	2	-13	-1	-32	-10	-3	1	32	23	9	-0	-16	-8	2	3	11	0	0	0	0	-	-	-	-
Change in fair value of derivative financial instruments
-	0	0	0	0	8	27	125	152	144	0	0	0	-	0	-	-	-647	0	0	0	-	-	-	-
Changes in fair value of warrant liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	0	0	-
Total other income (expense)
-38	-175	-214	-182	-246	-187	-169	-216	-158	-153	-164	-134	-154	-157	-148	-120	-2,387	-2,422	-2,448	-2,461	-163	-106	0	0	0
Loss before income taxes
-12,542	-12,446	-13,660	-13,433	-14,173	-13,368	-12,600	-12,613	-13,489	-15,419	-17,214	-18,793	-19,638	-19,166	-19,075	0	0	-	0	-	-	-	-	-	-
Loss before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Provision for income taxes
-	-	0	0	-	0	0	0	0	0	0	0	0	0	1	0	0	-	0	-	-	-	0	-	-
Net loss
-12,542	-12,446	-13,660	-13,433	-14,173	-13,368	-12,600	-12,613	-13,489	-15,419	-17,214	-18,793	-19,638	-19,166	-19,134	-18,957	-19,263	-17,352	-14,029	-10,968	-7,066	-5,671	0	0	0
Preferred stock dividends and beneficial conversion
-	-	-	-	-	-	-	-	-	-	-	-	-	332	332	405	0	-	0	0	-	-	-	-	-
Preferred stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0
Net loss available to common stockholders
0	-	0	0	0	-	0	0	0	-	-17,214	-18,793	-19,971	-19,499	-19,466	-19,289	-19,335	-17,595	-14,442	-11,556	-7,754	-6,298	0	0	0
Net loss per common share - basic and diluted
-0.53	4.65	-3.95	-0.15	-8.25	-32.50	-10.67	-0.57	-0.75	0.44	-1.74	-3.73	-4.77	-21.11	-5.75	-0.37	-0.36	-48.17	-0.38	-0.84	-5.61	-3.22	-4.92	-4.49	-3.62
Weighted average shares outstanding - basic and diluted
7,393	-12,527	882	17,645	467	-8,986	305	5,826	4,055	2,240	1,883	1,128	1,043	-25,101	837	14,522	12,568	-17,926	12,261	6,449	493	462	362	362	362
Net loss
-12,542	-12,446	-13,660	-13,433	-14,173	-13,368	-12,600	-12,613	-13,489	-15,419	-17,214	-18,793	-19,638	-19,166	-19,134	-18,957	-19,263	-17,352	-14,029	-10,968	-7,066	-5,671	0	0	0
Other comprehensive income - foreign currency translations
32	-4	10	5	28	12	-11	-18	-40	-32	-7	-0	4	7	0	-0	-2	-1	-0	0	0	-	0	-	-
Comprehensive loss
-12,510	-12,450	-13,650	-13,428	-14,144	-13,355	-12,611	-12,632	-13,530	-15,451	-17,222	-18,794	-19,633	-19,159	-19,134	-18,958	-19,265	-17,353	-14,233	0	0	-	0	-	-
Product sales [Member]
Total revenue
2,014	2,168	2,187	2,154	2,282	2,395	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of products and services
967	911	965	995	1,100	1,222	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Laboratory Service Revenue [Member]
Total revenue
-	-	17	30	-	34	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaborations Revenue [Member]
Total revenue
1,075	1,325	1,231	1,156	811	516	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service [Member]
Cost of products and services
713	720	772	674	601	625	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-